Table 1 Clinical variables in patients with high and low expression of MFN2
Variable | MFN2 expression | P value | |
|---|---|---|---|
High expression | Low expression | ||
Sample size | 33 | 74 | |
Age, years | 0.179 | ||
> 50 | 15 (45.5%) | 44 (59.5%) | |
≤ 50 | 18 (54.5%) | 30 (40.5%) | |
Gender | 0.844 | ||
Male | 29 (87.9%) | 64 (86.5%) | |
Female | 4 (12.1%) | 10 (13.5%) | |
AFP, ng/mL | 0.420 | ||
< 20 | 10 (30.3%) | 17 (23.0%) | |
≥ 20 | 23 (69.7%) | 57 (77.0%) | |
Cirrhosis | 0.049 | ||
Yes | 30 (90.9%) | 55 (74.3%) | |
No | 3 (9.1%) | 19 (25.7%) | |
Tumor size, cm | 0.128 | ||
< 5 | 9 (27.3%) | 11 (14.9%) | |
≥ 5 | 24 (72.7%) | 63 (85.1%) | |
Differentiation | 0.202 | ||
Well-moderate | 6 (18.2%) | 7 (9.5%) | |
Poor-undifferentiated | 27 (81.8%) | 67 (90.5%) | |
TNM stage | 0.196 | ||
I–II | 15 (45.5%) | 24 (32.4%) | |
III–IV | 18 (54.5%) | 50 (67.6%) | |
Vascular invasion | 0.192 | ||
Yes | 4 (12.1%) | 17 (23.0%) | |
No | 29 (87.9%) | 57 (77.0%) | |